Phase I study of AG-120, an IDH1 mutant enzyme inhibitor: Results from the cholangiocarcinoma dose escalation and expansion cohorts.

被引：0
|
作者：
Lowery, Maeve Aine
Abou-Alfa, Ghassan K.
Burris, Howard A.
Janku, Filip
Shroff, Rachna T.
Cleary, James M.
Azad, Nilofer Saba
Goyal, Lipika
Maher, Elizabeth A.
Gore, Lia
Hollebecque, Antoine
Beeram, Muralidhar
Trent, Jonathan C.
Jiang, Liewen
Ishii, Yuko
Auer, Julia
Gliser, Camelia
Agresta, Samuel V.
Pandya, Shuchi Sumant
Zhu, Andrew X.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4013
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Ivosidenib (IVO; AG-120) in mutant IDH1 relapsed/refractory acute myeloid leukemia (R/R AML): Results of a phase 1 study.
    Pollyea, Daniel Aaron
    Dinardo, Courtney Denton
    de Botton, Stephane
    Stein, Eytan
    Roboz, Gail J.
    Mims, Alice S.
    Swords, Ronan T.
    Altman, Jessica K.
    Collins, Robert
    Mannis, Gabriel N.
    Uy, Geoffrey L.
    Donnellan, William Bruce
    Pigneux, Arnaud
    Fathi, Amir Tahmasb
    Liu, Hua
    Wu, Bin
    Attar, Eyal C.
    Tallman, Martin S.
    Stone, Richard M.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Clinical safety and activity in a phase I trial of AG-120, a first in class, selective, potent inhibitor of the IDH1-mutant protein, in patients with IDH1 mutant positive advanced hematologic malignancies
    Pollyea, D. A.
    de Botton, S.
    Fathi, A. T.
    Stein, E. M.
    Tallman, M. S.
    Agresta, S.
    Bowden, C.
    Fan, B.
    Prah, M.
    Yang, H.
    Yen, K.
    Stone, R. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 195 - 195
  • [23] Ivosidenib (IVO; AG-120) in IDH1-Mutant Relapsed or Refractory Myelodysplastic Syndrome: Updated Results from a Phase 1 Study
    DiNardo, Courtney D.
    Foran, James M.
    Watts, Justin M.
    Stein, Eytan M.
    De Botton, Stephane
    Fathi, Amir T.
    Prince, Gabrielle T.
    Stein, Anthony S.
    Stone, Richard M.
    Patel, Prapti A.
    Tallman, Martin S.
    Choe, Sung
    Wang, Hongfang
    Zhang, Vickie
    Dai, David
    Fan, Bin
    Yen, Katherine E.
    Kapsalis, Stephanie K.
    Hickman, Denice
    Agresta, Samuel V.
    Liu, Hua
    Wu, Bin
    Attar, Eyal C.
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S340 - S340
  • [24] A PHASE 1, OPEN-LABEL, PERIOPERATIVE STUDY OF IVOSIDENIB (AG-120) AND VORASIDENIB (AG-881) IN RECURRENT IDH1 MUTANT, LOW-GRADE GLIOMA: UPDATED RESULTS
    Mellinghoff, Ingo
    Cloughesy, Timothy
    Wen, Patrick
    Taylor, Jennie
    Maher, Elizabeth
    Arrillaga-Romany, Isabel
    Peters, Katherine
    Choi, Changho
    Ellingson, Benjamin
    Lin, Alexander
    Thakur, Sunitha
    Nicolay, Brandon
    Lu, Min
    Le, Kha
    Yin, Feng
    Tai, Feng
    Schoenfeld, Steven
    Pandya, Shuchi S.
    Hassan, Islam
    Steelman, Lori
    Clarke, Jennifer
    NEURO-ONCOLOGY, 2019, 21 : 28 - 28
  • [25] PHASE 1 STUDY OF AG-881, AN INHIBITOR OF MUTANT IDH1 AND IDH2: RESULTS FROM THE RECURRENT/PROGRESSIVE GLIOMA POPULATION
    Mellinghoff, Ingo
    Penas-Prado, Marta
    Peters, Katherine
    Cloughesy, Timothy
    Burris, Howard
    Maher, Elizabeth
    Janku, Filip
    Cote, Gregory
    De La Fuente, Macarena
    Clarke, Jennifer
    Steelman, Lori
    Le, Kha
    Xu, Huansheng
    Sonderfan, Alison
    Hummel, Diana
    Schoenfeld, Steven
    Yen, Katharine
    Pandya, Shuchi
    Wen, Patrick
    NEURO-ONCOLOGY, 2018, 20 : 18 - 18
  • [26] Pharmacokinetic/pharmacodynamic (PK/PD) profile of AG-120 in patients with IDH1-mutant cholangiocarcinoma from a phase 1 study of advanced solid tumors.
    Fan, Bin
    Goyal, Lipika
    Lowery, Maeve Aine
    Pandya, Shuchi Sumant
    Manyak, Erika
    Le, Kha
    Jiang, Liewen
    Auer, Julia
    Dai, David
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] Mutant IDH1 Inhibitor Ivosidenib (IVO; AG-120) in Combination with Azacitidine (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)
    DiNardo, Courtney D.
    Stein, Anthony S.
    Stein, Eytan M.
    Fathi, Amir T.
    Frankfurt, Olga
    Schuh, Andre C.
    Doehner, Hartmut
    Martinelli, Giovanni
    Raffoux, Emmanuel
    Tan, Peter
    Zeidan, Amer
    de Botton, Stephane
    Kantarjian, Hagop M.
    Stone, Richard M.
    Lam, Du
    Wang, Xiwei
    Gong, Jing
    Kapsalis, Stephanie M.
    Hickman, Denice
    Zhang, Vickie
    Winkler, Thomas
    Daigle, Scott
    Vyas, Paresh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S217 - S218
  • [28] Ivo-Nivo: A Phase II Study of the IDH1 Inhibitor Ivosidenib (AG-120) in Combination with the Checkpoint Blockade Inhibitor Nivolumab for Patients with IDH1 Mutated Relapsed/Refractory AML and High Risk MDS
    Chandhok, Namrata S.
    Wei, Wei
    Halene, Stephanie
    Prebet, Thomas
    BLOOD, 2019, 134
  • [29] ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation.
    Lowery, Maeve Aine
    Abou-Alfa, Ghassan K.
    Valle, Juan W.
    Kelley, Robin Kate
    Goya, Lipika
    Shroff, Rachna T.
    Javle, Milind M.
    Borad, Mitesh J.
    Cleary, James M.
    El-Khoueiry, Anthony B.
    Bendell, Johanna C.
    Macarulla, Teresa
    Vogel, Arndt
    Korth, Christopher
    Jiang, Liewen
    Gliser, Camelia
    Wu, Bin
    Agresta, Samuel V.
    Pandya, Shuchi Sumant
    Zhu, Andrew X.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Determination of IDH1 Mutational Burden and Clearance Via Next-Generation Sequencing in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Inhibitor of Mutant IDH1
    DiNardo, Courtney D.
    de Botton, Stephane
    Stein, Eytan M.
    Roboz, Gail J.
    Swords, Ronan T.
    Pollyea, Daniel A.
    Fathi, Amir T.
    Collins, Robert
    Altman, Jessica K.
    Flinn, Ian W.
    Mannis, Gabriel N.
    Mims, Alice S.
    Foran, James M.
    Pigneux, Arnaud
    Prince, Gabrielle T.
    Uy, Geoffrey L.
    Tallman, Martin S.
    Kantarjian, Hagop M.
    Liu, Hua
    Attar, Eyal C.
    Sacolick, Jennifer
    Yen, Katharine
    Hurov, Jonathan B.
    Choe, Sung
    Wu, Bin
    Stone, Richard M.
    BLOOD, 2016, 128 (22)
12345